140 related articles for article (PubMed ID: 15507206)
1. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis.
AbdAlla S; Lother H; Langer A; el Faramawy Y; Quitterer U
Cell; 2004 Oct; 119(3):343-54. PubMed ID: 15507206
[TBL] [Abstract][Full Text] [Related]
2. Factor XIIIA (cross)links AT1 receptors to atherosclerosis.
Ogawa S; Glass CK
Cell; 2004 Oct; 119(3):313-4. PubMed ID: 15507203
[TBL] [Abstract][Full Text] [Related]
3. Double trouble for type 1 angiotensin receptors in atherosclerosis.
Thomas WG
N Engl J Med; 2005 Feb; 352(5):506-8. PubMed ID: 15689592
[No Abstract] [Full Text] [Related]
4. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
5. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
Kurdi M; De Mello WC; Booz GW
Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
[TBL] [Abstract][Full Text] [Related]
6. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
Higuchi S; Ohtsu H; Suzuki H; Shirai H; Frank GD; Eguchi S
Clin Sci (Lond); 2007 Apr; 112(8):417-28. PubMed ID: 17346243
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
[TBL] [Abstract][Full Text] [Related]
9. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
Daugherty A; Rateri DL; Lu H; Inagami T; Cassis LA
Circulation; 2004 Dec; 110(25):3849-57. PubMed ID: 15596561
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
[TBL] [Abstract][Full Text] [Related]
14. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation.
Shibata E; Powers RW; Rajakumar A; von Versen-Höynck F; Gallaher MJ; Lykins DL; Roberts JM; Hubel CA
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1009-16. PubMed ID: 16787961
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
[TBL] [Abstract][Full Text] [Related]
17. Type 1 angiotensin receptor (AT1-R)-mediated decrease in type 2 angiotensin receptor mRNA level is dependent on Gq and extracellular signal-regulated kinase 1//2 in AT1-R-transfected PC12 cells.
Saito M; Shinohara Y; Sasaki H; Netsu Y; Yoshida M; Nakahata N
J Neuroendocrinol; 2008 Mar; 20(3):299-308. PubMed ID: 18208547
[TBL] [Abstract][Full Text] [Related]
18. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
19. Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor.
Redondo-Müller MA; Stevanovic-Walker M; Barker S; Puddefoot JR; Vinson GP
Endocr Relat Cancer; 2008 Mar; 15(1):277-88. PubMed ID: 18310294
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells.
Zhao X; Li X; Trusa S; Olson SC
Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
